Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

The perfect circle brings Luke Ellis back to FRM

Thursday, November 22, 2012

amb
Luke Ellis
By Beverly Chandler, Opalesque London:

In his role as chief executive officer of FRM, Man Group’s newly remodelled fund of funds business, Luke Ellis has every right to feel that he got his baby back. Ellis joined Blaine Tomlinson at FRM in 1998, built the fund of funds’ firm FRM up through its independent years, and then left to take up the good life down on the farm (literally).

He returned to the hedge fund world in 2011, to the Man Group and now gloriously, has been reunited with his business with the Man Group’s purchase of FRM in May 2012. Seeing the FRM logo go up on the wall of the Man Group’s reception had a sentimental appeal for Ellis, he reveals in an interview with Opalesque.

The newly re-modelled FRM includes the remains of Man Group’s other fund of fund businesses, including the Swiss based firm RMF, which had suffered a near catastrophic fall in assets through significant exposures to Madoff.

The combined FRM was completely integrated before the London Olympics were finished and Ellis is now spearheading a $19bn fund of fund business which, despite the torrid time the industry generally and Man in particular has endured over the last five years, is still a larger pot of cash than FRM had at its independent peak.

"The good thing about bringing the two businesses together is that from a shareholder's point of view, the operational efficiency is important and from a client’s......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its